Evidence map›Paper›PMID 15908374›Full record

ArticleInfection and immunity2005

Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo.

Yen-Tung A Teng, Deeqa Mahamed, Bhagirath Singh

Abstract read
In one paragraph

Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. The role of osteoimmunology in periodontal disease.BioMed research international · 2013
    Review
  9. Langerhans cells down-regulate inflammation-driven alveolar bone loss.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The role of T cells in osteoporosis, an update.International journal of clinical and experimental pathology · 2009
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Yen-Tung A TengLab. of Molecular Microbial Immunity, Eastman Dental Center, University of Rochester Medical Centre, Box 683, 625 Elmwood Ave., Rochester, NY 14620, USA. andy_teng@urmc.rochester.edu
Deeqa Mahamed
Bhagirath Singh
University of Rochester · USWestern University · CA

Funding

Immunity and Periodontal Breakdown in Diabetic NOD MiceR21DE014473 · NIDCR · UNIVERSITY OF WESTERN ONTARIO · PI TENG, YEN-TUNG ANDY · 2001 to 2002
$160k
IDENTIFY ANTIGENIC DETERMINANTS OF HUMAN PERIODONTITISR03DE012969 · NIDCR · UNIVERSITY OF WESTERN ONTARIO · PI TENG, YEN-TUNG ANDY · 2000 to 2001
$50k
NIDCR NIH HHS DE 12969NIDCR NIH HHS DE 14473
6 · The paper itself

Abstract

Recent studies have shown the biological and clinical significance of signaling pathways of osteogenic cytokines RANKL-RANK/OPG in controlling osteoclastogenesis associated with bone pathologies, including rheumatoid arthritis, osteoporosis, and other osteolytic disorders. In contrast to the inhibitory effect of gamma interferon (IFN-gamma) on RANKL-mediated osteoclastogenesis reported recently, alternative new evidence is demonstrated via studies of experimental periodontitis using humanized NOD/SCID and diabetic NOD mice and clinical human T-cell isolates from diseased periodontal tissues, where the presence of increasing IFN-gamma is clearly associated with (i) enhanced Actinobacillus actinomycetemcomitans-specific RANKL-expressing CD4(+) Th cell-mediated alveolar bone loss during the progression of periodontal disease and (ii) a concomitant and significantly increased coexpression of IFN-gamma in RANKL(+) CD4(+) Th cells. Therefore, there are more complex networks in regulating RANKL-RANK/OPG signaling pathways for osteoclastogenesis in vivo than have been suggested to date.

Indexed as

AdultAggregatibacter actinomycetemcomitansAlveolar Bone LossAnimalsCarrier ProteinsCD4-Positive T-LymphocytesFemaleHumansInterferon-gammaMaleMembrane GlycoproteinsMiceMice, Inbred BALB CRANK LigandReceptor Activator of Nuclear Factor-kappa BSignal TransductionCarrier ProteinsInterferon-gammaMembrane GlycoproteinsRANK LigandReceptor Activator of Nuclear Factor-kappa BTNFRSF11A protein, humanTnfrsf11a protein, mouseTNFSF11 protein, humanTnfsf11 protein, mouse

Identifiers

PMID15908374
PMCPMC1111859
OpenAlexW2157596901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.